Advertisement
Screener

AdvisorShares Investments LLC Historic Quarter Change: Foreign ADRs, New

AdvisorShares Investments LLC historic quarter change: Foreign ADRs, New

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, AdvisorShares Investments LLC opened 4 positions, added to 7, reduced 6 and sold out of 8.

  • Q2 2025: Stock ASCENDIS PHARMA A/S - ADR; Country of operation —; Class ADR; Shares before 0.
  • Q3 2024: Stock CARNIVAL CORP; Country of operation —; Class ADR; Shares before 0.
  • Q1 2024: Stock MARATHON OIL CORP; Country of operation United States; Class ADR; Shares before 0.
  • Q1 2024: Stock AVADEL PHARMACEUTICALS-AD; Country of operation —; Class ADR; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1425930), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-11); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-28); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-10); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-05); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-04); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-13); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-07); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025ASCENDIS PHARMA A/S - ADR
CUSIP 04351P101
ADR06,518+6,518$0$1,125,007+$1,125,0072025-08-04
Q3 2024CARNIVAL CORP
CUSIP 143658300
ADR07,000+7,000$0$129,360+$129,3602024-11-14
Q1 2024MARATHON OIL CORP
CUSIP 565849106
United StatesADR020,200+20,200$0$572,468+$572,4682024-05-14
Q1 2024AVADEL PHARMACEUTICALS-AD
CUSIP 05337M104
ADR031,765+31,765$0$536,511+$536,5112024-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
KIRR MARBACH & CO LLC /IN/United States$0.549B57
LMG Wealth Partners, LLCUnited States$0.549B154
Wick Capital Partners, LLCUnited States$0.548B231
Rockport Wealth LLCUnited States$0.549B101
Atlas Legacy Advisors, LLCUnited States$0.550B300
Tufton Capital ManagementUnited States$0.550B126
Bienville Capital Management, LLCUnited States$0.550B74
Marino Management, LLCUnited States$0.547B11
Harvest Investment Services, LLCUnited States$0.547B346
AIRE ADVISORS, LLCUnited States$0.547B166